跳至主要内容
临床试验/JPRN-jRCT1050220128
JPRN-jRCT1050220128进行中(未招募)Unknown

Patient prognosis evaluation with retrospective data in severe perinatal, benign perinatal or infantile HPP: A pooled analysis from the post-marketing study and perinatal findings surveillance - HPP-PERINATAL study

Sawai Hideaki0 个研究点目标入组 40 人开始时间: 2022年12月8日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 1. At the time of the PMS data lock in July 2021, Strensiq Specified drug use-results survey (post-marketing survey) Patients should have have provided data to PMS prior the data base lock date above.
  • 2. Patients diagnosed with perinatal severe hypophosphatasia, perinatal benign hypophosphatasia, or infantile hypophosphatasia
  • 3. A patient whose legal representative or patient can give written consent to provide patient information and a patient whose mother can give written consent to provide maternal information.

排除标准

  • 1. Patients diagnosed with non-perinatal and non-infantile hypophosphatasia
  • 2. Patients in whom fetal ultrasound image data including the number of weeks of gestation before and after 28 ~ 31 weeks of gestation cannot be obtained

研究者

发起方
Sawai Hideaki

相似试验

Patient prognosis evaluation with retrospective data... | 临床试验